Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-induced Bone Loss: Two Years of Follow-up

R. J. Sebaldt St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

J. D. Adachi St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

W. G. Bensen St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

F. Bianchi St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

A. Cividano St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

G. L. Craig St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

A. Cranney St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

E. Kaminska St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

M. Gordon St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

M. Steele St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

C. Goldsmith St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada

show all

References

Adachi J D, Steele M, Gordon M, et al. Nasal salmon calcitonin in the prevention of corticosteroid-induced osteoporosis (abstr). J Bone Miner Res 1992; 7: S193
Google Scholar
Lukert B P, Johnson B E, Robinson R G. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992; 7: 1063–9
PubMed Web of Science ®Google Scholar
Reid I R, King A R, Alexander C J, Ibbertson H K. Prevention of steroid-induced osteoporosis with (3-amino-l-hydroxypropylidene)-l,l-bisphosphonate (APD). Lancet 1988; 1: 143–6
PubMed Web of Science ®Google Scholar
Watts N B, Harris S T, Genant H K, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 73–9
PubMed Web of Science ®Google Scholar
Mulder H, Snelder H AA. Effect of cyclical etidronate regimen on prophylaxis of bone loss of glucocorticoid (Prednisone) therapy in postmenopausal women (abstr). J Bone Miner Res 1992; 7: S331
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-induced Bone Loss: Two Years of Follow-up

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-induced Bone Loss: Two Years of Follow-up

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date